- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06180798
Cold Snare Endoscopic Mucosal Resection (C-EMR) Versus Hot Snare Endoscopic Mucosal Resection (H-EMR) for Large Colorectal Polyps (10-20 mm)
Cold Snare Endoscopic Mucosal Resection (C-EMR) Versus Hot Snare Endoscopic Mucosal Resection (H-EMR) for Large Colorectal Polyps (10-20 mm) - A Randomised Control Trail.
OBJECTIVES The aim of the study is to compare the efficacy of cold snare EMR versus hot snare EMR for non-pedunculated polyps 10-20mm in size with respect to complete resection rates and adverse events.
DESIGN : A Randomised interventional study. Sample size: 330
Study Overview
Status
Conditions
Detailed Description
- This procedure will be performed by Endoscopists having above 3 years of experience you will be in the left lateral position under propofol sedation.
- In Both groups (a mixture of saline and blue dye will be injected beneath the surface layer,and then a snare(is a ring shaped device used to cut polyp after surrounding it- like a rubber band ) will be used to remove tissue without using heat in Cold Endoscopic mucosal resection group and using electrosurgical unit (to control bleeding and to rapidly dissect soft tissue in surgery) by EndoCut Q mode (ensures safe and effective removal of large lesions in particular large polyps) in Hot Endoscopic mucosal resection group.
After polypectomy (the surgical removal of a polyp) the area is inspected for residual polyp (presence of any type of tissue) using NBI (Narrow band imaging) and if present, will be CUT OFF.
- A Standard snare ( snare is a ring shaped device used to cut polyp after surrounding it- like a rubber band) is used to cut the polyps
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Krithi Krishna Koduri, MD
- Phone Number: 91 9870083545
- Email: drkrithivk@gmail.com
Study Contact Backup
- Name: Nitin Jagtap, MD
- Phone Number: 91 9182859523
- Email: Docnits13@gmail.com
Study Locations
-
-
Telanagana
-
Hyderabad, Telanagana, India, 500082
- Recruiting
- Krithi Krishna Koduri
-
Contact:
- Nitin Jagtap, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult above 18 years
- polyp size greater than 5-10mm.
Exclusion Criteria:
- Inflammatory bowel disease
- Familial Polyposis Syndromes
- Patient who is unable to understand study protocol or not consenting
- Severe coagulopathy (INR Greater than 1.5 platelets)
- Receiving antiplatelets withing 5 days of procedure
- If antiplatelets stopped for 5 days-they were restarted on next day after procedure.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: cold snare endoscopic mucosal resection (C-EMR)
All procedures will be performed by experienced endoscopists (>3 years of experience/>1000 polypectomies) with the patient in the left lateral position under propofol sedation.submucosal
injection of saline mixed with methylene blue will be used (no epinephrine) followed by resection using snare without using electrocautery in C-EMR group.The polyp size will be assessed by boston biopsy forceps (open jaws -7mm) or boston jumbo biopsy forceps (open jaws 10mm) or submucosal injection needle (Olympus (4mm)).
A standard snare will be used.After polypectomy, the area is inspected for residual polyp using NBI and if present, will be resected using biopsy forceps.
|
All procedures will be performed by experienced endoscopists (>3 years of experience/>1000 polypectomies) with the patient in the left lateral position under propofol sedation. The polyp size will be assessed by boston biopsy forceps (open jaws -7mm) or boston jumbo biopsy forceps (open jaws 10mm) or submucosal injection needle (Olympus (4mm)). A standard snare will be used . submucosal injection of saline mixed with methylene blue will be used (no epinephrine) followed by resection using snare without using electrocautery in C-EMR group.After polypectomy, the area is inspected for residual polyp using NBI and if present, will be resected using biopsy forceps. Bleeding will be assessed for 2 mins to decide upon requirement of immediate hemostatic methods in the form of clipping or electrocoagulation. |
|
Sham Comparator: Hot snare endoscopic mucosal resection (H-EMR)
All procedures will be performed by experienced endoscopists (>3 years of experience/>1000 polypectomies) with the patient in the left lateral position under propofol sedation.Using ERBE electrosurgical unit - EndoCut Q mode (effect interval duration) and forced coagulation mode in H-EMR group.The polyp size will be assessed by boston biopsy forceps (open jaws -7mm) or boston jumbo biopsy forceps (open jaws 10mm) or submucosal injection needle (Olympus (4mm)).
A standard snare will be used.After polypectomy, the area is inspected for residual polyp using NBI and if present, will be resected using biopsy forceps.
|
All procedures will be performed by experienced endoscopists (>3 years of experience/>1000 polypectomies) with the patient in the left lateral position under propofol sedation. The polyp size will be assessed by boston biopsy forceps (open jaws -7mm) or boston jumbo biopsy forceps (open jaws 10mm) or submucosal injection needle (Olympus (4mm)). A standard snare will be used.submucosal injection of saline mixed with methylene blue will be used.Using ERBE electrosurgical unit - EndoCut Q mode (effect interval duration) and forced coagulation mode in H-EMR group. After polypectomy, the area is inspected for residual polyp using NBI and if present, will be resected using biopsy forceps. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess the complete resection rate
Time Frame: 1 YEAR
|
Primary outcome will be tested with chi-square test or Fisher's exact test.
The level of significance has been set at 5%.
To quantify the magnitude of the difference the relative risk and odds ratio will be calculated with 95% confidence interval.
|
1 YEAR
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary outcomes include procedure time, cost and adverse events.
Time Frame: 1 YEAR
|
Univariate and multivariate analysis will be done to determine which are the factors associated with clinical success and clinical recurrence.
Kaplan-Meier survival analysis will be done for appearance clinical recurrence.
|
1 YEAR
|
Collaborators and Investigators
Investigators
- Principal Investigator: Krithi Krishna Koduri, MD, Asian Institute of Gastroenterology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C-EMR VS H-EMR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polyps
-
Eisai Inc.PPD; Covance; Quest Pharmaceutical ServicesTerminated
-
Eisai Inc.Omnicare Clinical Research; MDS Pharma Services; Bio Analytical Research Corporation and other collaboratorsCompletedColonoscopy | Colon Polyps
-
Eisai Inc.PPD; MDS Pharma Services; Bio Analytical Research Corporation; Coghlan Group (Plasma...CompletedColonoscopy | Colon Polyps
-
Biotax Labs LTDRecruiting
-
Seoul National University HospitalCompletedColon PolypKorea, Republic of
-
Portuguese Oncology Institute, CoimbraCompleted
-
VA Greater Los Angeles Healthcare SystemTerminatedScreening of Colonic PolypsUnited States
-
Affiliated Hospital to Academy of Military Medical...UnknownSmall Colon Polyps | Linked Color Imagimg | Diminutive Colon PolypsChina
-
Imperial College LondonCompleted
-
California Pacific Medical Center Research InstituteCompletedColonic Polyps | Rectal PolypsUnited States
Clinical Trials on cold snare endoscopic mucosal resection (C-EMR)
-
Indiana UniversityUniversity of Colorado, Denver; University of Alabama at Birmingham; John D.... and other collaboratorsEnrolling by invitationColon Cancer | Colon Adenoma | Colon Polyp | Serrated PolypUnited States
-
Oscar NogalesSpanish Society of Digestive EndoscopyCompletedColorectal Neoplasms | Adenoma Colon | Serrated Polyp | Serrated AdenomaSpain
-
Western Sydney Local Health DistrictCompletedColon Cancer | Colon Adenoma | Adenoma ColonAustralia
-
Unity Health TorontoNot yet recruiting10-20mm Colorectal Polyp
-
Fudan UniversityNot yet recruitingColorectal Sessile Serrated LesionChina
-
Western Sydney Local Health DistrictRecruitingColon Cancer | Colon Adenoma | Colorectal PolypAustralia
-
Western Sydney Local Health DistrictCompletedColorectal Cancer | AdenomaAustralia
-
Pirogov Russian National Research Medical UniversityRecruitingBenign Colon TumorsRussian Federation
-
Qingwei JiangCompleted
-
Instituto do Cancer do Estado de São PauloUniversity of Sao PauloCompletedColorectal Neoplasms | AdenomaBrazil